Interventional therapies, including transarterial chemoembolization (TACE), yttrium-90 selective internal radiation therapy (90Y SIRT), and ablation ...

Cathie Wood, head of Ark Investment Management, actively trades her favorite stocks, picking her spots whether the prices are ...

Researchers at Queen’s University Belfast have unveiled a pioneering method to generate high-quality proton beams using ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

New data show that external-beam radiation therapy yielded superior local control and progression-free survival vs TACE in ...

Democrats have long opposed honoring Thomas, a Georgia native who was accused of sexual harassment during his 1991 confirmation hearing.

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Ark Invest, through its ARK Fintech Innovation ETF ARKF -5.46% + Free Alerts , bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...

EST Cathie Wood’s ARK Investment buys 171K shares of Beam Therapeutics (BEAM) todayDiscover the Best Stocks and Maximize Your Portfolio: ...

Glioblastoma, the most common and lethal form of primary brain cancer, presents daunting challenges. Each year, around 14,500 people in the United States face this aggressive disease. Its invasive ...